Abdominal Imaging

, Volume 38, Issue 2, pp 397–411 | Cite as

Current concepts in the imaging of uterine sarcoma

  • Sree Harsha Tirumani
  • Vijayanadh Ojili
  • Alampady Krishna Prasad Shanbhogue
  • Najla Fasih
  • John G. Ryan
  • Caroline Reinhold


Recent advances in genetics and pathology have improved our understanding of diagnosis and staging of uterine sarcomas. The major types of uterine sarcomas include leiomyosarcoma, low-grade endometrial stromal sarcoma, undifferentiated endometrial sarcoma, adenosarcoma and carcinosarcoma. The distinctive biological behavior and poor overall survival of uterine sarcoma create challenges in the management of these tumors. We herein present a comprehensive review of taxonomy, epidemiology, pathology, imaging findings and natural history of a wide spectrum of uterine sarcomas.


Uterine sarcomas Leiomyosarcoma Endometrial stromal sarcoma Carcinosarcoma MRI 


  1. 1.
    Major FJ, Blessing JA, Silverberg SG, et al. (1993) Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71(Suppl 4):1702–1709PubMedCrossRefGoogle Scholar
  2. 2.
    Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A (2008) Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol 111:74–81PubMedCrossRefGoogle Scholar
  3. 3.
    Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 260:277–300CrossRefGoogle Scholar
  4. 4.
    Abeler VM, Royne O, Thoresen S, et al. (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54:355–364PubMedCrossRefGoogle Scholar
  5. 5.
    D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116:131–139PubMedCrossRefGoogle Scholar
  6. 6.
    Tavassoli FA, Devilee P (eds) (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC PressGoogle Scholar
  7. 7.
    Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104:177–178PubMedCrossRefGoogle Scholar
  8. 8.
    Wu TI, Yen TC, Lai CH (2011) Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 25:681–689PubMedCrossRefGoogle Scholar
  9. 9.
    Royal College of Pathologists (2011) Standards and datasets for reporting cancers. Dataset for histological reporting of uterine sarcomas. London: Royal College of PathologistsGoogle Scholar
  10. 10.
    Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I (2009) Clinical management of uterine sarcomas. Lancet Oncol 10:1188–1198PubMedCrossRefGoogle Scholar
  11. 11.
    Schwartz LB, Zawin M, Carcangui MA, Lange R, McCarthy S (1998) Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril 70:580–587PubMedCrossRefGoogle Scholar
  12. 12.
    Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H (2004) Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 20:998–1007PubMedCrossRefGoogle Scholar
  13. 13.
    Cornfield D, Israel G, Martel M, et al. (2010) MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 74:241–249CrossRefGoogle Scholar
  14. 14.
    Kapp DS, Shin JY, Chan JK (2008) Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 112:820–830PubMedCrossRefGoogle Scholar
  15. 15.
    Pelmus M, Penault-Llorca F, Guillou L, et al. (2009) Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 19:385–390PubMedCrossRefGoogle Scholar
  16. 16.
    Renzulli P, Weimann R, Barras JP, Carrel TP, Candinas D (2009) Low-grade endometrial stromal sarcoma with inferior vena cava tumor thrombus and intracardiac extension: radical resection may improve recurrence free survival. Surg Oncol 18:57–64PubMedCrossRefGoogle Scholar
  17. 17.
    Nucci MR, Harburger D, Koontz J, Dal Cin P, Sklar J (2007) Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 31:65–70PubMedCrossRefGoogle Scholar
  18. 18.
    Gandolfo N, Gandolfo NG, Serafini G, Martinoli C (2000) Endometrial stromal sarcoma of the uterus: MR and US findings. Eur Radiol 10:776–779PubMedCrossRefGoogle Scholar
  19. 19.
    Koyama T, Togashi K, Konishi I, et al. (1999) MR imaging of endometrial stromal sarcoma: correlation with pathologic findings. AJR Am J Roentgenol 173:767–772PubMedCrossRefGoogle Scholar
  20. 20.
    Fujii S, Kaneda S, Tsukamoto K, et al. (2010) Diffusion-weighted imaging of uterine endometrial stromal sarcoma: a report of 2 cases. J Comput Assist Tomogr 34:377–379PubMedCrossRefGoogle Scholar
  21. 21.
    Tamai K, Koyama T, Saga T, et al. (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18:723–730PubMedCrossRefGoogle Scholar
  22. 22.
    Furukawa R, Akahane M, Yamada H, et al. (2010) Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review. J Magn Reson Imaging 31:975–979PubMedCrossRefGoogle Scholar
  23. 23.
    Thomas MB, Keeney GL, Podratz KC, Dowdy SC (2009) Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer 19:253–256PubMedCrossRefGoogle Scholar
  24. 24.
    Shah JP, Bryant CS, Kumar S, et al. (2008) Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 112:1102–1108PubMedCrossRefGoogle Scholar
  25. 25.
    Garg G, Shah JP, Toy EP, et al. (2010) Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 118:8–13PubMedCrossRefGoogle Scholar
  26. 26.
    Silva EG, Deavers MT, Malpica A (2007) Undifferentiated carcinoma of the endometrium: a review. Pathology 39:134–138PubMedCrossRefGoogle Scholar
  27. 27.
    Rha SE, Byun JY, Jung SE, et al. (2003) CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 181:1369–1374PubMedCrossRefGoogle Scholar
  28. 28.
    Chourmouzi D, Boulogianni G, Zarampoukas T, Drevelengas A (2003) Sonography and MRI of tamoxifen-associated Müllerian adenosarcoma of the uterus. AJR Am J Roentgenol 181:1673–1675PubMedCrossRefGoogle Scholar
  29. 29.
    Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363–381PubMedCrossRefGoogle Scholar
  30. 30.
    Szklaruk J, Tamm EP, Choi H, Varavithya V (2003) MR imaging of common and uncommon large pelvic masses. Radiographics 23:403–424PubMedCrossRefGoogle Scholar
  31. 31.
    Farhat MH, Hobeika EM, Moumneh G, Nassar AH (2007) Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report. J Med Case Rep 1:103PubMedCrossRefGoogle Scholar
  32. 32.
    Kim SA, Jung JS, Ju SJ, Kim YT, Kim KR (2011) Mullerian adenosarcoma with sarcomatous overgrowth in the pelvic cavity extending into the inferior vena cava and the right atrium. Pathol Int 61:445–448PubMedCrossRefGoogle Scholar
  33. 33.
    Kernochan LE, Garcia RL (2009) Carcinoasarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw 7:550–557PubMedGoogle Scholar
  34. 34.
    Kanthan R, Senger JL (2011) Uterine carcinosarcomas (malignant mixed Müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. doi:10.1155/2011/470795
  35. 35.
    Teo SY, Babagbemi KT, Peters HE, Mortele KJ (2008) Primary malignant mixed Müllerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. AJR Am J Roentgenol 191:278–283PubMedCrossRefGoogle Scholar
  36. 36.
    Bharwani N, Newland A, Tunariu N, et al. (2010) MRI appearances of uterine malignant mixed Müllerian tumors. AJR Am J Roentgenol 195:1268–1275PubMedCrossRefGoogle Scholar
  37. 37.
    Genever AV, Abdi S (2011) Can MRI predict the diagnosis of endometrial carcinosarcoma? Clin Radiol 66:621–624PubMedCrossRefGoogle Scholar
  38. 38.
    Ohguri T, Aoki T, Watanabe H, et al. (2002) MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 12:2737–2742PubMedGoogle Scholar
  39. 39.
    Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA (2007) Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31:1653–1661PubMedCrossRefGoogle Scholar
  40. 40.
    Huang GS, Chiu LG, Gebb JS, Gunter MJ, et al. (2007) Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 107:513–517PubMedCrossRefGoogle Scholar
  41. 41.
    Levy A, Medjhoul A, Caramella C, et al. (2011) Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging 33:1020–1027PubMedCrossRefGoogle Scholar
  42. 42.
    Fujii S, Matsusue E, Kigawa J, et al. (2008) Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 18:384–389PubMedCrossRefGoogle Scholar
  43. 43.
    Namimoto T, Yamashita Y, Awai K, et al. (2009) Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 19:2756–2764CrossRefGoogle Scholar
  44. 44.
    Kato H, Kanematsu M, Furui T, et al. (2008) Carcinosarcoma of the uterus: radiologic–pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging. Magn Reson Imaging 26:1446–1450PubMedCrossRefGoogle Scholar
  45. 45.
    Tsujikawa T, Yoshida Y, Mori T, et al. (2008) Uterine tumors: pathophysiologic imaging with 16α-[18F] fluoro-17β-estradiol and 18F-fluorodeoxyglucose PET—initial experience. Radiology 248:599–605PubMedCrossRefGoogle Scholar
  46. 46.
    Nagamatsu A, Umesaki N, Li L, Tanaka T (2010) Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas. Oncol Rep 23:1069–1076PubMedGoogle Scholar
  47. 47.
    Kao YH, Saad U, Tan AE, Magsombol BM, Padhy AK (2011) Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas. Acta Radiol 52:463–466PubMedCrossRefGoogle Scholar
  48. 48.
    FIGO Committee on Gynecologic Oncology (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104:179CrossRefGoogle Scholar
  49. 49.
    Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104PubMedCrossRefGoogle Scholar
  50. 50.
    Seddon BM, Davda R (2011) Uterine sarcomas—recent progress and future challenges. Eur J Radiol 78:30–40PubMedCrossRefGoogle Scholar
  51. 51.
    Gadducci A, Cosio S, Romanini A, Genazzani A (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65:129–142PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Sree Harsha Tirumani
    • 1
    • 3
  • Vijayanadh Ojili
    • 2
  • Alampady Krishna Prasad Shanbhogue
    • 2
  • Najla Fasih
    • 3
  • John G. Ryan
    • 3
  • Caroline Reinhold
    • 1
  1. 1.Department of Diagnostic Radiology, Montreal General HospitalMcGill University Health CentreMontrealCanada
  2. 2.Department of RadiologyUniversity of Texas HSC at San AntonioSan AntonioUSA
  3. 3.Department of Diagnostic ImagingThe Ottawa HospitalOttawaCanada

Personalised recommendations